Pfizer released new data last week confirming Paxlovid reduced the risk of hospitalization or death by 89% in high-risk adults.
An interim analysis of a second study of the pill has so far shown a 70% reduction in hospitalization among standard-risk adults, Pfizer said.will work well against the Omicron variant because of the way the drug works.The EUA is for the treatment of mild-to-moderate COVID-19 in adults and some children 12 years and older "who are at high risk for progression to severe COVID-19, including hospitalization or death," the FDA said.
"Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset," it added."Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic,” said Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research.
Pfizer chairman and CEO Albert Bourla called the EUA a "tremendous example of how science will help us ultimately defeat this pandemic, which, even two years in, continues to disrupt and devastate lives across the world." "This breakthrough therapy ... will change the way we treat COVID-19 and hopefully help reduce some of the significant pressures facing our health care and hospital systems," he added in a statement.in a statement later Wednesday said the authorization was "a significant step forward in our path out of the pandemic.""Today’s action is a testament to the power of science and the result of American innovation and ingenuity.
"Recognizing that this pill takes time to make given the complex scientific process, production will ramp up in the months ahead," the president added.whether to authorize Merck and Ridgeback Biotherapeutics' antiviral COVID-19 pill, known as molnupiravir.that molnupiravir reduced the risk of hospitalization or death for patients with mild or moderate COVID-19 by about 30%, based on a study of more than 1,400 adults.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
U.S. FDA set to authorize Pfizer, Merck COVID-19 pills this week - Bloomberg NewsThe U.S. Food and Drug Administration is set to authorize COVID-19 treatment pills from both Pfizer Inc and Merck as early as Wednesday, Bloomberg News reported on Tuesday, citing people familiar with the matter.
Weiterlesen »
FDA Authorizes Pfizer Antiviral Pill for COVID-19The FDA was also expected to authorize an antiviral pill from Merck, but as of Wednesday afternoon, only Pfizer's had been authorized for use.
Weiterlesen »
FDA authorizes first pill to treat Covid-19The FDA authorizes the first pill to treat Covid-19. Pfizer's Paxlovid is meant to be taken at home before people are sick enough to be hospitalized.
Weiterlesen »
Cleveland-area hospitals battling latest Covid-19 surge put ad in local paper that reads: 'Help''Help' said the ad Sunday in the Cleveland Plain-Dealer, a response to the latest Covid-19 health crisis exploding in Northern Ohio, nearly two years into a pandemic that has killed more than 810,000 Americans and battered many of the nation's hospitals.
Weiterlesen »
Column: NHL skips Olympics again, cites COVID-19 uncertaintyThe NHL took a hard pass on the Beijing Olympics, citing uncertainty over the spread of COVID-19 and marking the second straight Winter Games the world's best players will miss.
Weiterlesen »
8 At-Home, Rapid COVID-19 Tests That You Can Buy Online TodayResults are just minutes away.
Weiterlesen »